Richtlijn CVRM feb2013 - KNMP

Kooter 2010 Kooter AJ en Smulders YM. Bij hypertensie liever chloortalidon dan hydrochloorthiazide. NTvG 2010;
154: A1608.
Kotseva 2009 Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U, EUROASPIRE Studt Group.
EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug
therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009;
16: 121-137.
Kreijl 2004 Kreijl CF, Knaap AGAC, Busch MCM, Havelaar AH, Kramers PGN, Kromhout D, van Leeuwen
FXR, van Leent-Loenen HMJA, Ocke MC, Verkley H. Ons eten gemeten. Gezonde voeding en
voedsel in Nederland RIVM rapport 270555007, Volksgezondheid Toekomst Verkenning, 2004.
veilig
Kremers 2011 Kremers B. praktijk versus theorie: Geen bewijs voor lage dosering dipyridamol. PW 2011; 21:
29.
Kuusi 1988 Kuusi T, Taskinen MR, Nikkila EA. Lipoproteins, lipolyitc enzymes and hormonal status in
hypothyroid women at different levels of substitution. J Clin Endocrinol Metab 1988; 66: 51- 56.
Kwok 2012 Kwok CS, Jeevanantham V, Dawn B, Loke YK.No consistent evidence of differential
cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: Metaanalysis.
Int J Cardiol 2012. 2012 Mar 29. [Epub ahead of print]
Lanas 2007 Lanas A, Scheiman J. Low-dose aspirin and upper gastrointestninal damage: epidemiology,
prevention and treatment. Curr Med Res Opin 2007; 23 (1): 163-173.
Lanas 2011 Lanas A, Wu P, Medin J, Mills EJ. Low doses of acetylsalicylic acid increase risk of gastro
intestinal bleeding in a meta-analysis. Clin Gastroenterol Hepatol 2011; 9 (9): 762-768.
Lang 1996 Lang JE, wang P, Glueck CJ. Mypoathy associated with lipid lowering therapy in patients with
previously undiagnosed or undertreated hypothyreoidism. Clin Chim Acta 1996; 254: 85-92
Langhorne 2004 Langhorne P, Dennis MS. Stroke units: the next 10 years. Lancet 2004; 363: 834-835.
Lardizabal 2011 lardizabal JA, Deedwania PC. The anti-ischemic and anti-anginal properties of statins. Curr
Athereoscler Rep 2011; 13 (1): 43-50.
Lassen 2009
Lassen 2010
Lassen MR, Raskob GE, Gallus A, Pineo G, Chen D, Portman RJ. Apixaban or enoxaparin for
thromboprophylaxis after knee replacement. N Eng J MEd 2009; 361 (6): 594-604.
Lassen MR, Gallus A, Raskob GE, Pineo G, Chen D, Ramirez LM: ADVANCE 3 investigators.
Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. N Eng J Med 2010;
363 (26): 2487-98.
Laufs 1998 Laufs U, La Fata V, Plutzky J, Liao JK. Upregulation of endothelial nitic oxide synthase by
HMG CoA reductase inhibitors. Circulation 1998; 97: 1129-1135.
Laufs 2003 Laufs U. Beyond lipid-lowering.: effect of statins on endothelial nitroc oxide. Eur J Clin
Pharmacol 2003; 58: 719-731.
Laufs 2001 Laufs U, Wassmann S, Hilgers S, Ribaudo N, Bohm M, Nickening G. Rapid effects on vascular
function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic
Am J Cardiol 2001; 88: 1306-1307.
men.
Law 2000 Law MR. Plant sterol and stanol margarines and health. West J Med 2000; 173: 43-47.
law 2003 Law MR, Wald NJ, Rudnicka AR. Quantifying effects of statins on low density lipoprotein
cholesterol, ischeamic haert disease, and stroke: systematic review and meta-analysis. BMJ 2003;
326: 1423.
Law 2009
Law MR. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: metaanalysis
of 147 randomised trials in the context of expectations from prospective epidemiological
studies. BMJ 2009; 338: b1665.
Lee 2011 Lee M, Saver JL, Towfighi A, Chow J, Ovbiagele B. Efficacy of fibrates for cardiovascular risk
reduction in persons with atherogenic dyslipidemia: a meta-analysis. Atherosclerosis. 2011;
217(2):492-498.
92
CONCEPT